<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38539395</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9067</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>19</Day></PubDate></JournalIssue><Title>Children (Basel, Switzerland)</Title><ISOAbbreviation>Children (Basel)</ISOAbbreviation></Journal><ArticleTitle>Neurofilament Light Chain Concentration in Cerebrospinal Fluid in Children with Acute Nontraumatic Neurological Disorders.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">360</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/children11030360</ELocationID><Abstract><AbstractText>(1) Introduction: This pilot study aimed to analyze neurofilament light chain levels in cerebrospinal fluid (cNfL) in a cohort of children with different acute nontraumatic neurological conditions. (2) Methods: This prospective observational cohort study consisted of 35 children aged 3 months to 17 years and was performed from November 2017 to December 2019. Patients' clinical data were reviewed, and patients were assigned to the following groups: <i>n</i> = 10 (28.6%) meningitis, 5 (14.3%) Bell's palsy, 7 (20.0%) febrile non-CNS infection, 3 (8.6%) complex febrile seizure, 4 (11.4%) idiopathic intracranial hypertension, and 6 (17.1%) others. cNfL levels were measured using a sensitive single-molecule array assay. (3) Results: The cNfL levels [median (range)] in children with meningitis were 120.5 pg/mL (58.1-205.4), in Bell's palsy 88.6 pg/mL (48.8-144.5), in febrile non-CNS infection 103.9 pg/mL (60.1-210.8), in complex febrile seizure 56 pg/mL (53.2-58.3), and in idiopathic intracranial hypertension 97.1 pg/mL (60.1-124.6). Within the meningitis group, children with Lyme neuroborreliosis (LNB) had significantly higher cNfL concentrations (median 147.9 pg/mL; range 87.8-205.4 pg/mL) than children with enterovirus meningitis (72.5 pg/mL; 58.1-95.6 pg/mL; <i>p</i> = 0.048) and non-significantly higher cNfL levels when compared to Bell's palsy (88.6 pg/mL; 48.8-144.5 pg/mL; <i>p</i> = 0.082). There was no correlation between cNfL levels and age. (4) Conclusions: Although the number of patients in this pilot study cohort is limited, higher cNfL levels in children with LNB compared to those with viral meningitis (significant) and Bell's palsy (trend) may indicate the potential of cNfL as a biomarker in the differential diagnosis of pediatric meningitis and facial palsy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Geis</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-6941-3247</Identifier><AffiliationInfo><Affiliation>University Children's Hospital Regensburg (KUNO) at the Hospital St. Hedwig of the Order of St. John, University of Regensburg, 93049 Regensburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gutzeit</LastName><ForeName>Svena</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Children's Hospital Regensburg (KUNO) at the Hospital St. Hedwig of the Order of St. John, University of Regensburg, 93049 Regensburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Disse</LastName><ForeName>Sigrid</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Children's Hospital Regensburg (KUNO) at the Hospital St. Hedwig of the Order of St. John, University of Regensburg, 93049 Regensburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuhle</LastName><ForeName>Jens</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospital, University of Basel, 4001 Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multiple Sclerosis Centre, Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital, University of Basel, 4001 Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fouzas</LastName><ForeName>Sotiris</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7617-9076</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, University Hospital of Patras, 265 04 Patras, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wellmann</LastName><ForeName>Sven</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9230-6266</Identifier><AffiliationInfo><Affiliation>Department of Neonatology, University Children's Hospital Regensburg (KUNO) at the Hospital St. Hedwig of the Order of St. John, University of Regensburg, 93049 Regensburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Children (Basel)</MedlineTA><NlmUniqueID>101648936</NlmUniqueID><ISSNLinking>2227-9067</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bell’s facial palsy</Keyword><Keyword MajorTopicYN="N">Lyme neuroborreliosis LNB</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">child</Keyword><Keyword MajorTopicYN="N">meningitis</Keyword><Keyword MajorTopicYN="N">neurofilament light chain NfL</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>28</Day><Hour>1</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38539395</ArticleId><ArticleId IdType="pmc">PMC10969464</ArticleId><ArticleId IdType="doi">10.3390/children11030360</ArticleId><ArticleId IdType="pii">children11030360</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kozak S., Kaminiów K., Kozak K., Paprocka J. Lyme Neuroborreliosis in Children. Brain Sci. 2021;11:758. doi: 10.3390/brainsci11060758.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11060758</ArticleId><ArticleId IdType="pmc">PMC8226969</ArticleId><ArticleId IdType="pubmed">34200467</ArticleId></ArticleIdList></Reference><Reference><Citation>Marzano L.A.S., Batista J.P.T., de Abreu Arruda M., de Freitas Cardoso M.G., de Barros J.L.V.M., Moreira J.M., Liu P.M.F., Teixeira A.L., Silva A.C.S.E., de Miranda A.S. Traumatic brain injury biomarkers in pediatric patients: A systematic review. Neurosurg. Rev. 2022;45:167–197. doi: 10.1007/s10143-021-01588-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10143-021-01588-0</ArticleId><ArticleId IdType="pubmed">34170424</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil M., Teunissen C.E., Otto M., Piehl F., Sormani M.P., Gattringer T., Barro C., Kappos L., Comabella M., Fazekas F., et al. Neurofilaments as biomarkers in neurological disorders. Nat. Rev. Neurol. 2018;14:577–589. doi: 10.1038/s41582-018-0058-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0058-z</ArticleId><ArticleId IdType="pubmed">30171200</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambertsen K.L., Soares C.B., Gaist D., Nielsen H.H. Neurofilaments: The C-Reactive Protein of Neurology. Brain Sci. 2020;10:56. doi: 10.3390/brainsci10010056.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci10010056</ArticleId><ArticleId IdType="pmc">PMC7016784</ArticleId><ArticleId IdType="pubmed">31963750</ArticleId></ArticleIdList></Reference><Reference><Citation>Bridel C., van Wieringen W.N., Zetterberg H., Tijms B.M., Teunissen C.E., Alvarez-Cermeño J.C., Andreasson U., Axelsson M., Bäckström D.C., Bartos A., et al. Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis. JAMA Neurol. 2019;76:1035–1048. doi: 10.1001/jamaneurol.2019.1534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.1534</ArticleId><ArticleId IdType="pmc">PMC6580449</ArticleId><ArticleId IdType="pubmed">31206160</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan A., Nixon R.A. Neurofilament Proteins as Biomarkers to Monitor Neurological Diseases and the Efficacy of Therapies. Front. Neurosci. 2021;15:689938. doi: 10.3389/fnins.2021.689938.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.689938</ArticleId><ArticleId IdType="pmc">PMC8503617</ArticleId><ArticleId IdType="pubmed">34646114</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong Y.Y.M., Bruijstens A.L., Barro C., Michalak Z., Melief M.J., Wierenga A.F., van Pelt E.D., Neuteboom R.F., Kuhle J., Hintzen R.Q. Serum neurofilament light chain in pediatric MS and other acquired demyelinating syndromes. Neurology. 2019;93:e968–e974. doi: 10.1212/WNL.0000000000008057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008057</ArticleId><ArticleId IdType="pubmed">31383792</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayoumy S., Verberk I.M.W., Vermunt L., Willemse E., den Dulk B., van der Ploeg A.T., Pajkrt D., Nitz E., van den Hout J.M.P., van der Post J., et al. Neurofilament light protein as a biomarker for spinal muscular atrophy: A review and reference ranges. Clin. Chem. Lab. Med. 2024 doi: 10.1515/cclm-2023-1311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2023-1311</ArticleId><ArticleId IdType="pubmed">38215341</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinhofer I., Rommer P., Gleiss A., Ponleitner M., Zierfuss B., Waidhofer-Söllner P., Fourcade S., Grabmeier-Pfistershammer K., Reinert M.C., Göpfert J., et al. Biomarker-based risk prediction for the onset of neuroinflammation in X-linked adrenoleukodystrophy. EBioMedicine. 2023;96:104781. doi: 10.1016/j.ebiom.2023.104781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104781</ArticleId><ArticleId IdType="pmc">PMC10497986</ArticleId><ArticleId IdType="pubmed">37683329</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendel E.M., Bertolini A., Kousoulos L., Rauchenzauner M., Schanda K., Wegener-Panzer A., Baumann M., Reindl M., Otto M., Rostásy K. Serum neurofilament light-chain levels in children with monophasic myelin oligodendrocyte glycoprotein-associated disease, multiple sclerosis, and other acquired demyelinating syndrome. Mult. Scler. 2022;28:1553–1561. doi: 10.1177/13524585221081090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/13524585221081090</ArticleId><ArticleId IdType="pubmed">35282740</ArticleId></ArticleIdList></Reference><Reference><Citation>Green N.S., Rosano C., Bangirana P., Opoka R., Munube D., Kasirye P., Kawooya M., Lubowa S.K., Mupere E., Conroy A., et al. Neurofilament light chain: A potential biomarker for cerebrovascular disease in children with sickle cell anaemia. Br. J. Haematol. 2023;203:460–467. doi: 10.1111/bjh.19036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.19036</ArticleId><ArticleId IdType="pmc">PMC10615726</ArticleId><ArticleId IdType="pubmed">37581299</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsson B., Alberg L., Cullen N.C., Michael E., Wahlgren L., Kroksmark A.K., Rostasy K., Blennow K., Zetterberg H., Tulinius M. NFL is a marker of treatment response in children with SMA treated with nusinersen. J. Neurol. 2019;266:2129–2136. doi: 10.1007/s00415-019-09389-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09389-8</ArticleId><ArticleId IdType="pmc">PMC6687695</ArticleId><ArticleId IdType="pubmed">31123861</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahim P., Darin N., Andreasson U., Blennow K., Jennions E., Lundgren J., Månsson J.E., Naess K., Törnhage C.J., Zetterberg H., et al. Cerebrospinal fluid brain injury biomarkers in children: A multicenter study. Pediatr. Neurol. 2013;49:31–39.e2. doi: 10.1016/j.pediatrneurol.2013.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pediatrneurol.2013.02.015</ArticleId><ArticleId IdType="pubmed">23827424</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelhak A., Petermeier F., Benkert P., Schädelin S., Oechtering J., Maleska Maceski A., Kabesch M., Geis T., Laub O., Leipold G., et al. Serum neurofilament light chain reference database for individual application in paediatric care: A retrospective modelling and validation study. Lancet Neurol. 2023;22:826–833. doi: 10.1016/S1474-4422(23)00210-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(23)00210-7</ArticleId><ArticleId IdType="pubmed">37524100</ArticleId></ArticleIdList></Reference><Reference><Citation>Geis T., Gutzeit S., Fouzas S., Ambrosch A., Benkert P., Kuhle J., Wellmann S. Serum Neurofilament light chain (NfL) levels in children with and without neurologic diseases. Eur. J. Paediatr. Neurol. 2023;45:9–13. doi: 10.1016/j.ejpn.2023.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpn.2023.05.003</ArticleId><ArticleId IdType="pubmed">37236127</ArticleId></ArticleIdList></Reference><Reference><Citation>Mygland A., Ljøstad U., Fingerle V., Rupprecht T., Schmutzhard E., Steiner I. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur. J. Neurol. 2010;17:8-e4. doi: 10.1111/j.1468-1331.2009.02862.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2009.02862.x</ArticleId><ArticleId IdType="pubmed">19930447</ArticleId></ArticleIdList></Reference><Reference><Citation>Disanto G., Barro C., Benkert P., Naegelin Y., Schädelin S., Giardiello A., Zecca C., Blennow K., Zetterberg H., Leppert D., et al. Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis. Ann. Neurol. 2017;81:857–870. doi: 10.1002/ana.24954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24954</ArticleId><ArticleId IdType="pmc">PMC5519945</ArticleId><ArticleId IdType="pubmed">28512753</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann P., Leutmezer F., Zach H., Wurm R., Stattmann M., Ponleitner M., Petzold A., Zetterberg H., Berger T., Rommer P., et al. Serum neurofilament light chain withstands delayed freezing and repeated thawing. Sci. Rep. 2020;10:19982. doi: 10.1038/s41598-020-77098-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-77098-8</ArticleId><ArticleId IdType="pmc">PMC7672085</ArticleId><ArticleId IdType="pubmed">33203974</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann P., Ponleitner M., Rommer P.S., Haslacher H., Mucher P., Leutmezer F., Petzold A., Wotawa C., Lanzenberger R., Berger T., et al. Author Correction: Seven day pre-analytical stability of serum and plasma neurofilament light chain. Sci. Rep. 2022;12:6514. doi: 10.1038/s41598-022-10916-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-10916-3</ArticleId><ArticleId IdType="pmc">PMC9021204</ArticleId><ArticleId IdType="pubmed">35444204</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber H., Blennow K., Zetterberg H., Boada M., Jeromin A., Weninger H., Nuñez-Llaves R., Aguilera N., Ramis M., Simrén J., et al. Biomarkers of Alzheimer’s disease and neurodegeneration in dried blood spots-A new collection method for remote settings. Alzheimer’s Dement. 2024 doi: 10.1002/alz.13697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.13697</ArticleId><ArticleId IdType="pmc">PMC11032540</ArticleId><ArticleId IdType="pubmed">38284555</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosadas C., Taylor G.P. Pre-analytical long-term stability of neopterin and neurofilament light in stored cerebrospinal fluid samples. Clin. Chem. Lab. Med. 2023;61:1230–1234. doi: 10.1515/cclm-2022-0904.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2022-0904</ArticleId><ArticleId IdType="pubmed">36692943</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson D., Chan D., Chang L., Mathis R., Verberk I., Montalban X., Comabella M., Fissolo N., Bielekova B., Masvekar R., et al. Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: Toward a clinical blood test for neuronal injury. Clin. Chem. Lab. Med. 2024;62:322–331. doi: 10.1515/cclm-2023-0518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2023-0518</ArticleId><ArticleId IdType="pubmed">37702323</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinert M.C., Benkert P., Wuerfel J., Michalak Z., Ruberte E., Barro C., Huppke P., Stark W., Kropshofer H., Tomic D., et al. Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis. Neurol. Neuroimmunol. Neuroinflamm. 2020;7:e749. doi: 10.1212/NXI.0000000000000749.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000749</ArticleId><ArticleId IdType="pmc">PMC7238898</ArticleId><ArticleId IdType="pubmed">32404429</ArticleId></ArticleIdList></Reference><Reference><Citation>Mens H., Fjordside L., Gynthersen R.M.M., Ørbæk M.T., Andersen Å., Andreasson U., Blennow K., Sellebjerg F., Zetterberg H., Lebech A.M. Neurofilament Light in Cerebrospinal Fluid is Associated With Disease Staging in European Lyme Neuroborreliosis. J. Cent. Nerv. Syst. Dis. 2022;14:11795735221098126. doi: 10.1177/11795735221098126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/11795735221098126</ArticleId><ArticleId IdType="pmc">PMC9272052</ArticleId><ArticleId IdType="pubmed">35832609</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattsson N., Bremell D., Anckarsäter R., Blennow K., Anckarsäter H., Zetterberg H., Hagberg L. Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism. BMC Neurol. 2010;10:51. doi: 10.1186/1471-2377-10-51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-10-51</ArticleId><ArticleId IdType="pmc">PMC2902447</ArticleId><ArticleId IdType="pubmed">20569437</ArticleId></ArticleIdList></Reference><Reference><Citation>Mens H., Fjordside L., Gynthersen R., Ørbaek M., Andersen Å., Andreasson U., Blennow K., Sellebjerg F., Zetterberg H., Lebech A.M. Plasma neurofilament light significantly decreases following treatment in Lyme neuroborreliosis and is not associated with persistent symptoms. Eur. J. Neurol. 2023;30:1371–1377. doi: 10.1111/ene.15707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15707</ArticleId><ArticleId IdType="pubmed">36692938</ArticleId></ArticleIdList></Reference><Reference><Citation>Chekrouni N., van Soest T.M., Brouwer M.C., Willemse E.A.J., Teunissen C.E., van de Beek D. CSF Neurofilament Light Chain Concentrations Predict Outcome in Bacterial Meningitis. Neurol. Neuroimmunol. Neuroinflamm. 2022;9:e1123. doi: 10.1212/NXI.0000000000001123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001123</ArticleId><ArticleId IdType="pmc">PMC8669658</ArticleId><ArticleId IdType="pubmed">34903639</ArticleId></ArticleIdList></Reference><Reference><Citation>Grønhøj M.H., Sejbaek T., Hansen R.W., Larsen L., Dahl M., Schierbeck J., Poulsen F.R. Serum levels of neurofilament light chain, neuron-specific enolase and S100 calcium-binding protein B during acute bacterial meningitis: A prospective cohort study. Infect. Dis. 2021;53:409–419. doi: 10.1080/23744235.2021.1883730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1883730</ArticleId><ArticleId IdType="pubmed">33583314</ArticleId></ArticleIdList></Reference><Reference><Citation>Le N.D., Muri L., Grandgirard D., Kuhle J., Leppert D., Leib S.L. Evaluation of neurofilament light chain in the cerebrospinal fluid and blood as a biomarker for neuronal damage in experimental pneumococcal meningitis. J. Neuroinflamm. 2020;17:293. doi: 10.1186/s12974-020-01966-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01966-3</ArticleId><ArticleId IdType="pmc">PMC7539528</ArticleId><ArticleId IdType="pubmed">33028339</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsushige T., Ichiyama T., Kajimoto M., Okuda M., Fukunaga S., Furukawa S. Serial cerebrospinal fluid neurofilament concentrations in bacterial meningitis. J. Neurol. Sci. 2009;280:59–61. doi: 10.1016/j.jns.2009.01.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2009.01.021</ArticleId><ArticleId IdType="pubmed">19237165</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruinsma R.A., Smulders C.A., Vermeeren Y.M., van Kooten B., Cats E.A., van Hees B., van Hensbroek M.B., Hovius J.W., Zomer T.P. Acute facial nerve palsy in children in a Lyme disease-endemic area in the Netherlands. Eur. J. Clin. Microbiol. Infect. Dis. 2021;40:2455–2458. doi: 10.1007/s10096-021-04273-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-021-04273-8</ArticleId><ArticleId IdType="pubmed">33977412</ArticleId></ArticleIdList></Reference><Reference><Citation>Beier D., Korsbæk J.J., Madsen J.S., Olsen D.A., Molander L.D., Hagen S.M., Teunissen C., Beier C.P., Jensen R.H. Neurofilament light chain as biomarker in idiopathic intracranial hypertension. Cephalalgia. 2020;40:1346–1354. doi: 10.1177/0333102420944866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102420944866</ArticleId><ArticleId IdType="pubmed">32727204</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoche T., Gaus V., Haffner P., Kowski A. Neurofilament light chain marks severity of papilledema in idiopathic intracranial hypertension. Neurol. Sci. 2023;44:2131–2135. doi: 10.1007/s10072-023-06616-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-023-06616-z</ArticleId><ArticleId IdType="pmc">PMC10175309</ArticleId><ArticleId IdType="pubmed">36689008</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>